Citations 1268
Type 1 monoclonal cryoglobulinemia: Clinical presentation and outcomes.
Lacy, Martha Q. , Hayman, Suzanne R. , Kapoor, Prashant , Hwa, Yi L. , Fonder, Amie , Hobbs, Miriam, Zeldenrust, Steven R., Lust, John A., Kyle, Robert A. , Kumar, Shaji , Sidana, Surbhi , Rajkumar, S. Vincent , Dispenzieri, Angela , Gertz, Morie A. , Buadi, Francis K. , Dingli, David , Gonsalves, Wilson I. , Leung, Nelson
Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 8062-8062
Importance of pharmacovigilance in the era of small molecules: Role of pharmacist consultation with ixazomib (IXA) in multiple myeloma (MM).
Finnes, Heidi D. , Kumar, Shaji , LaPlant, Betsy, Lacy, Martha Q. , Merten, Julianna A., Bartoo, Gabriel , Kapoor, Prashant , Gertz, Morie A. , Buadi, Francis K. , Dispenzieri, Angela , McCullough, Kristen , Rajkumar, S. Vincent
Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 8058-8058
Changes in serum alkaline phosphatase levels to predict response to ixazomib-based therapy in patients with newly diagnosed multiple myeloma.
Tandon, Nidhi , Lacy, Martha Q. , Kapoor, Prashant , Hwa, Yi L. , Fonder, Amie , Hobbs, Miriam, Hayman, Suzanne R. , Zeldenrust, Steven R., Lust, John A., Kumar, Shaji , Buadi, Francis K. , Leung, Nelson , Go, Ronald S. , Dingli, David , Gertz, Morie A. , Lin, Yi , Dispenzieri, Angela , Drake, Matthew T. , Gonsalves, Wilson I. , Rajkumar, S. Vincent
Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 8053-8053
Phase I venetoclax monotherapy for relapsed/refractory multiple myeloma.
Kumar, Shaji , Vij, Ravi , Pegourié, Brigitte, Benboubker, Lotfi , Gasparetto, Cristina, Diehl, Susan, Alzate, Stefanie, Dunbar, Martin, Zhu, Ming , Maciag, Paulo , Verdugo, Maria E., Kaufman, Jonathan L. , Mıkhael, Joseph , Facon, Thierry T.F. , Gasparetto, Cristina , Amiot, Martine , Moreau, Philippe , Ross, Jeremy A. , Agarwal, Suresh K, Leverson, Joel D. , Touzeau, Cyrille
Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 8032-8032
Immunoparesis in newly diagnosed AL amyloidosis as a marker for response and survival.
Kumar, Shaji , Lacy, Martha Q. , Zeldenrust, Steven R., Hayman, Suzanne R. , Kourelis, Taxiarchis , Lust, John A., Kapoor, Prashant , Kyle, Robert A. , Muchtar, Eli , Dispenzieri, Angela , Buadi, Francis K. , Leung, Nelson , Gonsalves, Wilson I. , Chakraborty, Rajshekhar , Dingli, David , Lin, Yi , Go, Ronald S. , Rajkumar, S. Vincent , Gertz, Morie A.
Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 8016-8016
Quantification of circulating clonal plasma cells (cPCs) via multiparametric flow cytometry (MFC) to identify patients with smoldering multiple myeloma (SMM) at high risk of progression.
Timm, Michael, Morice, William G. , Lacy, Martha Q. , Kapoor, Prashant , Hayman, Suzanne R. , Lust, John A., Zeldenrust, Steven R., Kourelis, Taxiarchis , Hwa, Yi L. , Kyle, Robert A. , Kumar, Shaji , Gonsalves, Wilson I. , Rajkumar, S. Vincent , Morice, William George , Dispenzieri, Angela , Buadi, Francis K. , Dingli, David , Go, Ronald S. , Leung, Nelson , Gertz, Morie A.
Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 8015-8015
Phase Ib venetoclax combined with bortezomib and dexamethasone in relapsed/refractory multiple myeloma.
Chanan‐Khan, Asher , Agarwal, Amit , Kumar, Shaji , Diehl, Susan, Cordero, Jaclyn, Munasinghe, Wijith, Zhu, Ming , Maciag, Paulo , Verdugo, Maria E., Moreau, Philippe , Roberts, Andrew W. , Facon, Thierry T.F. , Touzeau, Cyrille , Ross, Jeremy A. , Salem, Ahmed Hamed , Leverson, Joel D. , Harrison, Simon J
Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 8011-8011
A phase I/II study of ixazomib (Ix) pomalidomide (POM) dexamethasone (DEX) in relapsed refractory (R/R) multiple myeloma: Initial results.
Krishnan, Amrita , Kapoor, Prashant , Kumar, Shaji , Htut, Myo , Karanes, Chatchada , Rosenzweig, Michael , Sahebi, Firoozeh , Somlo, George, Duarte, Lupe, Forman, Stephen J. , Palmer, Joycelynne Michelle , Lonial, Sagar , Nathwani, Nitya , Berdeja, Jesús G.
Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 8008-8008
Updated data from a phase II dose finding trial of single agent isatuximab (SAR650984, anti-CD38 mAb) in relapsed/refractory multiple myeloma (RRMM).
Martin, Thomas G. , Vij, Ravi , Cole, Craig E. , Atanackovic, Djordje , Zonder, Jeffrey A. , Bensinger, William, Zimmerman, Todd M., Lendvai, Nikoletta , Gasparetto, Cristina , Kumar, Shaji , Oprea, Corina, Richter, Joshua , Kaufman, Jonathan L. , Mıkhael, Joseph , Dimopoulos, Meletios Α. , Hari, Parameswaran , Ocio, Enrique M. , Charpentier, Éric , Strickland, Stephen Anthony , Miguel, Jesús F. San
Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 8005-8005
Dexamethasone, rituximab and cyclophosphamide (DRC) in relapsed/refractory (R/R) and treatment naïve (TN) Waldenström macroglobulinemia (WM).
Abeykoon, Jithma P. , Kumar, Shaji , King, Rebecca L. , Kyle, Robert A. , Hayman, Suzanne R. , Lacy, Martha Q. , Thompson, Carrie A. , Lust, John A., Ansell, Stephen M. , Kapoor, Prashant , Paludo, Jonas , Gertz, Morie A. , Buadi, Francis K. , Habermann, Thomas M. , Dingli, David , Witzig, Thomas E. , Dispenzieri, Angela , Go, Ronald S. , Gonsalves, Wilson I. , Rajkumar, S. Vincent
Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 7552-7552